Raffit Hassan Selected Research

Raffit Hassan Research Topics

Disease

91	Neoplasms (Cancer) 05/2024 - 11/2002
56	Mesothelioma 05/2024 - 11/2002
29	Malignant Mesothelioma 01/2022 - 06/2004
16	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2002
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2005
8	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2007
7	Disease Progression 01/2022 - 06/2010
7	Adenocarcinoma 01/2020 - 06/2004
7	Adenocarcinoma of Lung 01/2020 - 03/2007
5	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2007
4	Thymoma (Thymic Carcinoma) 10/2019 - 11/2016
4	Carcinoma (Carcinomatosis) 04/2017 - 05/2007
3	Capillary Leak Syndrome 01/2023 - 01/2013
3	Hairy Cell Leukemia 10/2013 - 12/2006
2	Melanoma (Melanoma, Malignant) 05/2024 - 07/2012
2	Ascites 01/2023 - 05/2004
2	Pneumonia (Pneumonitis) 01/2022 - 02/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2018
2	Leukemia 06/2014 - 10/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2007 - 11/2002
2	Ovarian Epithelial Carcinoma 09/2005 - 05/2005
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2024
1	Sepsis (Septicemia) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Atrial Fibrillation 01/2022
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2022
1	Neutropenia 01/2022
1	Liver Failure 01/2022
1	Fever (Fevers) 02/2021
1	Chills 02/2021
1	Carcinogenesis 12/2020

Drug/Important Bio-Agent (IBA)

67	MesothelinIBA 01/2023 - 11/2002
42	Immunotoxins (Immunotoxin)IBA 01/2023 - 11/2002
17	Monoclonal AntibodiesIBA 01/2018 - 05/2004
15	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2005
13	AntigensIBA 01/2023 - 10/2007
10	AntibodiesIBA 01/2023 - 05/2005
9	amatuximabIBA 01/2018 - 12/2007
8	Pemetrexed (MTA)FDA Link 01/2022 - 09/2011
7	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 08/2005
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
7	Differentiation AntigensIBA 01/2020 - 06/2004
7	SS1(dsFv)PE38IBA 04/2016 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2011
6	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2015 - 11/2002
6	ExotoxinsIBA 11/2014 - 05/2004
5	EpitopesIBA 01/2023 - 09/2005
5	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
5	LMB-100IBA 11/2020 - 03/2017
5	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2011
4	PlatinumIBA 01/2022 - 01/2018
4	Surface Antigens (Surface Antigen)IBA 11/2020 - 01/2006
4	avelumabIBA 10/2019 - 11/2016
4	Bacterial ToxinsIBA 03/2016 - 02/2010
3	anetumab ravtansineIBA 01/2022 - 12/2016
3	AsbestosIBA 12/2020 - 01/2016
3	B7-H1 AntigenIBA 01/2020 - 01/2019
3	Pentostatin (Nipent)FDA LinkGeneric 06/2014 - 06/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014 - 06/2011
3	VaccinesIBA 06/2014 - 02/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2010 - 08/2006
3	Tumor Biomarkers (Tumor Markers)IBA 07/2006 - 06/2004
3	ParaffinIBA 12/2005 - 11/2002
3	Formaldehyde (Formol)FDA Link 12/2005 - 11/2002
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
2	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2011
2	olaparibIBA 10/2021 - 01/2020
2	NivolumabIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2020
2	pembrolizumabIBA 11/2020 - 01/2020
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 03/2017
2	LigandsIBA 01/2019 - 11/2016
2	Histone Deacetylase InhibitorsIBA 10/2017 - 09/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2016 - 05/2005
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2015 - 06/2014
2	Immunoglobulin G (IgG)IBA 02/2015 - 05/2005
2	Immunoglobulin Variable RegionIBA 11/2014 - 12/2006
2	Antineoplastic Agents (Antineoplastics)IBA 06/2014 - 01/2006
2	Cancer VaccinesIBA 06/2014 - 03/2012
2	Neutralizing AntibodiesIBA 01/2013 - 06/2011
2	Messenger RNA (mRNA)IBA 11/2012 - 03/2007
2	Gemcitabine FDA Link 01/2012 - 12/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022
1	UbiquitinIBA 01/2021
1	IpilimumabIBA 01/2021
1	Interleukin-12 (IL 12)IBA 12/2020
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	Interleukin-3 (Interleukin 3)IBA 12/2020
1	CreatinineIBA 11/2020

Therapy/Procedure

45	Therapeutics 01/2023 - 11/2002
14	Immunotherapy 01/2022 - 08/2005
13	Drug Therapy (Chemotherapy) 01/2022 - 12/2007
2	Radiotherapy 01/2020 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Intravenous Administration 01/2022